Contrast-enhanced Magnetic Resonance Imaging: Clinical Trials

14 trials of Contrast-enhanced Magnetic Resonance Imaging, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 2 active not recruiting, 2 terminated, 1 not yet recruiting. 4 Not applicable, 3 Phase 2, 2 Phase 1, 2 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable4Active not recruiting 2, Completed 1, Withdrawn 1
Phase 23Completed 3
Phase 12Completed 1, Terminated 1
Phase 32Completed 1, Not yet recruiting 1
Early Phase 11Terminated 1

Follow Contrast-enhanced Magnetic Resonance Imaging: new trials by email Literature Review of Contrast-enhanced Magnetic Resonance Imaging trials Research Report on Contrast-enhanced Magnetic Resonance Imaging

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma
Chemical Exchange Saturation Transfer Magnetic Resonance Imaging, Contrast-enhanced Magnetic Resonance Imaging, Magnetic Resonance Imaging - Glioblastoma
Phase 3Not yet recruitingJonsson Comprehensive Cancer Center602026-12-012026-07-07
Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas
Fludeoxyglucose F-18, Gadoterate Meglumine, Contrast-enhanced Magnetic Resonance Imaging - Glioma
CompletedOHSU Knight Cancer Institute42023-12-112026-06-05
Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
Contrast-enhanced Magnetic Resonance Imaging, Ipilimumab, Nivolumab - Gliosarcoma, MGMT-Unmethylated Glioblastoma
Phase 2 / Phase 3CompletedNational Cancer Institute (NCI)1592020-09-012026-04-22
Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Locally Advanced Rectal Cancer
Contrast-enhanced Magnetic Resonance Imaging, Ferumoxytol - Locally Advanced Rectal Carcinoma, Stage III Rectal Cancer AJCC v7
Early Phase 1TerminatedOHSU Knight Cancer Institute22018-04-272021-09-10
Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts
Contrast-enhanced Magnetic Resonance Imaging, Digital Tomosynthesis Mammography, Quality-of-Life Assessment - Asymptomatic
Not applicableActive not recruitingECOG-ACRIN Cancer Research Group15162016-12-272026-02-25
NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer
Contrast-enhanced Magnetic Resonance Imaging, Fludeoxyglucose F-18, Fluorine F 18 Sodium Fluoride - Hormone-Resistant Prostate Cancer, Metastatic Malignant Neoplasm in the Bone
Phase 1TerminatedStanford University42015-04-012017-05-30
Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions
Contrast-enhanced Magnetic Resonance Imaging, Gadobutrol, Gadoxetate Disodium - Hepatocellular Carcinoma, Liver and Intrahepatic Bile Duct Disorder
Not applicableActive not recruitingM.D. Anderson Cancer Center1002014-10-132026-06-23
Voxel Based Diffusion Tensor Imaging in Predicting Response in Patients With Brain Metastases Undergoing Whole Brain Radiation Therapy or Stereotactic Radiosurgery
diffusion tensor imaging, whole-brain radiation therapy, stereotactic radiosurgery - Tumors Metastatic to Brain, Unspecified Adult Solid Tumor, Protocol Specific
Not applicableWithdrawnAlbert Einstein College of Medicine2013-04-012020-03-04
Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT
gallium Ga 68-edotreotide, positron emission tomography/computed tomography, indium In 111 pentetreotide - Adult Medulloblastoma, Childhood Medulloblastoma
Phase 2CompletedSue O'Dorisio682013-04-012021-09-22
Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Liver Cancer Receiving Transarterial Chemoembolization With Drug Eluting Beads
Perflutren Lipid Microspheres, Dynamic Contrast-Enhanced Ultrasound Imaging, Contrast-enhanced Magnetic Resonance Imaging - Hepatocellular Carcinoma
Phase 1CompletedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University152012-12-122025-05-02
The Leiden Nonischemic Cardiomyopathy Study
Transthoracic echocardiography, Exercise test, 24-hour Holter electrocardiogram - Cardiomyopathy, Dilated, Tachycardia, Ventricular
CompletedLeiden University Medical Center1482011-10-012020-02-20
IMC-A12 in Treating Patients With Advanced Liver Cancer
cixutumumab, computed tomography, contrast-enhanced magnetic resonance imaging - Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer
Phase 2CompletedNational Cancer Institute (NCI)242008-03-012014-05-23
Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin
contrast-enhanced magnetic resonance imaging - Cardiac Toxicity, Chemotherapeutic Agent Toxicity
CompletedUniversity of Nebraska102008-01-012023-11-03
Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI
Contrast-enhanced Magnetic Resonance Imaging, Mammography, Therapeutic Conventional Surgery - Ductal Breast Carcinoma In Situ, Stage IA Breast Cancer
Not applicableCompletedUniversity of Southern California3002005-11-202019-05-16

Conditions studied

Carcinoma, Hepatocellular (3)  ·  Arrhythmias, Cardiac (1)  ·  Brain Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Burkitt Lymphoma (1)  ·  Carcinoma, Intraductal, Noninfiltrating (1)  ·  Cardiomyopathy, Dilated (1)  ·  Cardiotoxicity (1)  ·  Digestive System Diseases (1)  ·  Glioblastoma (1)  ·  Glioma (1)  ·  Gliosarcoma (1)  ·  Hodgkin Disease (1)  ·  Immunoblastic Lymphadenopathy (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)

Sponsors

National Cancer Institute (NCI) (2)  ·  OHSU Knight Cancer Institute (2)  ·  Albert Einstein College of Medicine (1)  ·  ECOG-ACRIN Cancer Research Group (1)  ·  Jonsson Comprehensive Cancer Center (1)  ·  Leiden University Medical Center (1)  ·  M.D. Anderson Cancer Center (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)  ·  Stanford University (1)  ·  Sue O'Dorisio (1)  ·  University of Nebraska (1)  ·  University of Southern California (1)

Countries

United States (12)  ·  Germany (1)  ·  Netherlands (1)

Top investigators

Alexander Guimaraes (1)  ·  Andrei Iagaru (1)  ·  Andrew B Lassman (1)  ·  Christopher Comstock (1)  ·  Flemming Forsberg, PhD (1)  ·  Ghassan Abou-Alfa (1)  ·  Janio Szklaruk, MD, PHD (1)  ·  Kunal S Patel, MD (1)  ·  Linda Hovanessian-Larsen (1)  ·  M. Sue O' Dorisio, MD, PhD (1)  ·  Madhur Garg (1)  ·  Martin Pike, Ph.D. (1)  ·  Thomas R Porter, MD (1)

Results publications

PMID 32096852, PMID 32691060, PMID 35089806, PMID 40779733

NIH funding

N01CM62206 (1), P30CA008748 (1), P30CA013330 (1), P30CA014089 (1), P30CA036727 (1), P30CA086862 (1), P30CA124435 (1), R01CA167632 (1), U10CA180868 (1), UG1CA189828 (1)